The publication entitled “Lessons Learned from the National Heart, Lung, and Blood Institute COVID-19 Clinical Trials” describes the process, barriers and successes in the rapid implementation of medical interventional clinical trials addressing morbidity and mortality related to the COVID-19 pandemic.